Maestrini et al., 2000 - Google Patents
Identifying autism susceptibility genesMaestrini et al., 2000
View HTML- Document ID
- 5451737918919081484
- Author
- Maestrini E
- Paul A
- Monaco A
- Bailey A
- Publication year
- Publication venue
- Neuron
External Links
Snippet
‡ Department of Biology other PDDs; this was in marked contrast to the 10% concordance rate in DZ pairs. A similar range and pat-University of Bologna via Selmi 3 tern of difficulties is observed among a minority of relatives in family studies (Bailey et al., 1998). 40126 …
- 206010003805 Autism 0 title abstract description 43
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Maestrini et al. | Identifying autism susceptibility genes | |
Hyde et al. | Identification of 15 genetic loci associated with risk of major depression in individuals of European descent | |
Ebstein et al. | Genetics of human social behavior | |
Wingo et al. | DICER1 and microRNA regulation in post-traumatic stress disorder with comorbid depression | |
Lionel et al. | Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD | |
Cantor et al. | Replication of autism linkage: fine-mapping peak at 17q21 | |
Lauritsen et al. | A genome-wide search for alleles and haplotypes associated with autism and related pervasive developmental disorders on the Faroe Islands | |
Kilpatrick et al. | The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults | |
Valente et al. | Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36 | |
Perroud et al. | Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project | |
Posthuma et al. | A genomewide scan for intelligence identifies quantitative trait loci on 2q and 6p | |
Huguet et al. | The genetic landscapes of autism spectrum disorders | |
Yonan et al. | A genomewide screen of 345 families for autism-susceptibility loci | |
Anheim et al. | Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers | |
Alarcón et al. | Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene | |
Montag et al. | Oxytocin and oxytocin receptor gene polymorphisms and risk for schizophrenia: A case–control study | |
Fanous et al. | Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia | |
Krug et al. | TTC7B emerges as a novel risk factor for ischemic stroke through the convergence of several genome-wide approaches | |
Holt et al. | Linkage and candidate gene studies of autism spectrum disorders in European populations | |
Nuytemans et al. | Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease | |
Veenstra-Vanderweele et al. | Genetics of childhood disorders: XLVI. Autism, part 5: genetics of autism | |
Clark et al. | Replication of the LINGO1 gene association with essential tremor in a North American population | |
Corominas et al. | Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing | |
Adegbola et al. | Monoallelic expression of the human FOXP2 speech gene | |
Gauthier et al. | Mutation screening of FOXP2 in individuals diagnosed with autistic disorder |